[HTML] sciencedirect.com

[HTML][HTML] Ginsenosides for the treatment of metabolic syndrome and cardiovascular diseases: Pharmacology and mechanisms

W Fan, Y Huang, H Zheng, S Li, Z Li, L Yuan… - Biomedicine & …, 2020 - Elsevier
Epidemiological studies showed that the metabolic syndromes (MetS) and cardiovascular
diseases (CVDs) are responsible for a serious threat to human health worldwide. MetS is a …
被引用次数：123 相关文章

Ginsenosides for the treatment of metabolic syndrome and cardiovascular diseases: Pharmacology and mechanisms

W Fan, Y Huang, H Zheng, S Li, Z Li… - Biomedicine & …, 2020 - pubmed.ncbi.nlm.nih.gov
Epidemiological studies showed that the metabolic syndromes (MetS) and cardiovascular
diseases (CVDs) are responsible for a serious threat to human health worldwide. MetS is a …

Ginsenosides for the treatment of metabolic syndrome and cardiovascular diseases: Pharmacology and mechanisms.

W Fan, Y Huang, H Zheng, S Li, Z Li… - Biomedicine & …, 2020 - europepmc.org
Epidemiological studies showed that the metabolic syndromes (MetS) and cardiovascular
diseases (CVDs) are responsible for a serious threat to human health worldwide. MetS is a …

Ginsenosides for the treatment of metabolic syndrome and cardiovascular diseases: pharmacology and mechanisms.

W Fan, Y Huang, H Zheng, S Li, Z Li, L Yuan, X Cheng… - 2020 - cabidigitallibrary.org
Epidemiological studies showed that the metabolic syndromes (MetS) and cardiovascular
diseases (CVDs) are responsible for a serious threat to human health worldwide. MetS is a …

[引用][C] Ginsenosides for the treatment of metabolic syndrome and cardiovascular diseases: Pharmacology and mechanisms

W Fan, Y Huang, H Zheng, S Li, Z Li, L Yuan… - Biomedicine & …, 2020 - cir.nii.ac.jp
Ginsenosides for the treatment of metabolic syndrome and cardiovascular diseases:
Pharmacology and mechanisms | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …